A previous autopsy study of patients with amnestic-type mild cognitive impairment (MCI) suggested an overrepresentation of argyrophilic grain disease (AGD). We studied 34 patients who had diagnoses of amnestic MCI during progression to dementia and who came to autopsy. Neuropathologic evaluation included routine histochemical and immunohistochemical methods, including a 4-repeat tau-specific marker (ET3). AGD was found in association with a variety of neuropathologic diseases in 18 (53%) cases but was the primary pathologic finding in only one (3%) case. ET3 allowed the detection of AGD in 5 additional cases missed using standard techniques. Cases with AGD were significantly older than those without (mean, 94 vs 84 years; p < 0.004, rank sum test). No significant differences were found between groups for other demographic variables, association of AGD with neuropathologic findings of Alzheimer disease, Lewy body, or cerebrovascular disease, or global measures of cognitive function, although there was a nonsignificant trend towards worsening cognitive status in cases with AGD. AGD is a common pathologic finding in subjects who have been diagnosed with amnestic MCI.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.jnen.0000225312.11858.57DOI Listing

Publication Analysis

Top Keywords

argyrophilic grain
8
grain disease
8
mild cognitive
8
cognitive impairment
8
amnestic mci
8
pathologic finding
8
cases agd
8
agd
7
disease
4
disease demented
4

Similar Publications

Article Synopsis
  • Alzheimer’s disease (AD) is the most common cause of dementia, but there are other conditions like LATE (limbic-predominant age-related TDP-43 encephalopathy) that also produce similar symptoms, particularly in older adults.
  • Recent research shows that LATE can coexist with AD and may occur in individuals with cognitive impairment, leading to difficulty in clinical diagnosis due to the lack of direct biomarkers for TDP-43 pathology.
  • Understanding and recognizing non-AD conditions like LATE and primary age-related tauopathy is crucial for neurologists, especially for patients over 75 experiencing slow cognitive decline.
View Article and Find Full Text PDF
Article Synopsis
  • - The emergence of neuropsychiatric symptoms in middle-aged individuals poses diagnostic challenges, making it tough to distinguish between primary psychiatric disorders and early neurodegenerative diseases, especially when brain imaging shows no clear abnormalities.
  • - A case study of a 59-year-old woman showed initial symptoms similar to a mood disorder and behavioral frontotemporal dementia, but autopsy revealed a mix of Lewy body disease and tau-related changes.
  • - This case highlights the complexities of diagnosing late-onset neuropsychiatric symptoms, underlines their connection to dementia, and stresses the importance of accurate diagnosis for developing targeted therapies and improving clinical trial participation.
View Article and Find Full Text PDF
Article Synopsis
  • Recent research on late-life dementia highlights both neurodegenerative and vascular conditions contributing to the varied symptoms in patients, utilizing the Vallecas Alzheimer's Reina Sofía (VARS) cohort with over 550 participants and associated brain donations.
  • The study focused on 167 patients, primarily older women (79%) with an average age of 88, and found a significant presence of the ApoE-e4 gene variant (43%).
  • The main findings revealed that 79.6% had Alzheimer's disease, with a high prevalence of other conditions like vascular dementia and Lewy body dementia, and over 71.1% of the patients showed multiple neuropathological findings, indicating the complexity of dementia in this cohort.
View Article and Find Full Text PDF

Post-mortem neuropathology of idiopathic rapid eye movement sleep behaviour disorder: a case series.

Lancet Neurol

December 2024

Neurological Tissue Bank of the Biobank, FRCB-IDIBAPS, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain; Department of Pathology, Biomedical Diagnostic Center (CDB), Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.

Article Synopsis
  • The study examines post-mortem brain tissues from individuals diagnosed with idiopathic REM sleep behavior disorder (IRBD) to investigate its potential link to neurodegenerative diseases, specifically focusing on signs of neuronal loss and the presence of key protein deposits.
  • Researchers analyzed samples from 20 participants, most of whom were diagnosed with Lewy body disease, while a small number had Parkinson's disease-related conditions, revealing significant findings of neuronal damage associated with α-synuclein proteins, particularly in brain regions controlling REM sleep.
  • While the sample size limited the statistical analysis, the outcomes suggest a strong correlation between IRBD and neurodegenerative diseases, emphasizing the importance of these pathological features for understanding the progression
View Article and Find Full Text PDF

Purpose: Although neuropathological comorbidities, including Alzheimer's disease neuropathological change (AD-NC) and limbic-predominant age-related TAR DNA-binding protein 43encephalopathy neuropathological change (LATE-NC), are associated with medial temporal atrophy in patients with Lewy body disease (LBD), the diagnostic performance of magnetic resonance imaging (MRI)-derived indices remains unclear. This study aimed to investigate the diagnostic performance of MRI-derived indices representing medial temporal atrophy in differentiating between LBD with AD-NC and/or LATE-NC (mixed LBD [mLBD]) and without these comorbidities (pure LBD [pLBD]).

Methods: This study included 24 and 16 patients with pathologically confirmed mLBD and pLBD, respectively.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!